InsiderTrades.com logo
Vladimir Lenin was right…
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.
Shelly D. Guyer net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Shelly Guyer Biography and Net Worth

CFO of Invitae
Shelly D. Guyer serves as Chief Financial Officer of the Company. Ms. Guyer served as Chief Financial Officer of Veracyte, Inc., a genomic diagnostics company, from April 2013 to December 2016 and served as Veracyte’s Secretary from April 2013 to March 2014. Previously, she served as Chief Financial Officer and Executive Vice President of Finance and Administration of iRhythm Technologies, Inc., a digital healthcare company, from April 2008 to December 2012. From March 2006 to August 2007, Ms. Guyer served as Vice President of Business Development and Investor Relations of Nuvelo, Inc., a biopharmaceutical company. Prior to joining Nuvelo, Ms. Guyer worked at J.P. Morgan Securities and its predecessor companies for over 17 years, serving in a variety of roles including in healthcare investment banking. Ms. Guyer currently serves as a director of NGM Biopharmaceuticals, Inc., a publicly held biopharmaceutical company. Ms. Guyer holds an A.B. in Politics from Princeton University and an M.B.A. from the Haas School of Business at the University of California Berkeley.

What is Shelly D. Guyer's net worth?

The estimated net worth of Shelly D. Guyer is at least $11.96 as of May 15th, 2018. Ms. Guyer owns 39,865 shares of Invitae stock worth more than $12 as of December 22nd. This net worth estimate does not reflect any other investments that Ms. Guyer may own. Additionally, Ms. Guyer receives an annual salary of $430,440.00 as CFO at Invitae. Learn More about Shelly D. Guyer's net worth.

How old is Shelly D. Guyer?

Ms. Guyer is currently 64 years old. There are 6 older executives and no younger executives at Invitae. The oldest executive at Invitae is Dr. Randal W. Scott Ph.D., Co-Founder & Chairman of the Board, who is 66 years old. Learn More on Shelly D. Guyer's age.

What is Shelly D. Guyer's salary?

As the CFO of Invitae Co., Ms. Guyer earns $430,440.00 per year. There are 2 executives that earn more than Ms. Guyer. The highest earning executive at Invitae is Mr. Kenneth D. Knight, President, CEO & Director, who commands a salary of $1,400,000.00 per year. Learn More on Shelly D. Guyer's salary.

How do I contact Shelly D. Guyer?

The corporate mailing address for Ms. Guyer and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected]. Learn More on Shelly D. Guyer's contact information.

Has Shelly D. Guyer been buying or selling shares of Invitae?

Shelly D. Guyer has not been actively trading shares of Invitae during the last quarter. Learn More on Shelly D. Guyer's trading history.

Who are Invitae's active insiders?

Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.

Shelly D. Guyer Insider Trading History at Invitae

See Full Table

Shelly D. Guyer Buying and Selling Activity at Invitae

This chart shows Shelly D. Guyer's buying and selling at Invitae by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Invitae Company Overview

Invitae logo
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $0.00
Low: $0.00
High: $0.00

50 Day Range

MA: N/A

2 Week Range

Now: $0.00
Low: $0.02
High: $0.02

Volume

75 shs

Average Volume

23,716,614 shs

Market Capitalization

$80,103.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.